References
- Chen GT, Li J, Yan SS, Lin HJ, Wu JJ, Zhai XG, Song Y, Li JL. 2017. Biotransformation of 20(R)-panaxatriol by Mucor racemosus and the anti-hepatic fibrosis activity of some products. Nat. Prod. Res. 31(6):1880–1885.
- Debeleç-Bütüner B, Öztürk MB, Tağ Ö, Akgün IH, Yetik-Anacak G, Bedir E, Korkmaz KS. 2018. Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis. Steroids, 135:9–20.
- Fauce SR, Jamieson BD, Chin AC, Mitsuyasu RT, Parish ST, Ng HL, Kitchen CM, Yang OO, Harley CB, Effros RB. 2008. Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J. Immunol. 181:7400–7406.
- Feng LM, Ji S, Qiao X, Li ZW, Lin XH, Ye M. 2015. Biocatalysis of cycloastragenol by Syncephalastrum racemosum and Alternaria alternate to discover anti-aging derivatives. Adv. Synth. Catal. 357:1928–1940.
- Harley CB, Liu WM, Blasco M, Vera E, Andrews WH, Briggs LA, Raffaele JM. 2011. A natural product telomerase activator as part of a health maintenance program. Rejuv. Res. 14:45–56.
- Kuban M, Ongen G, Bedir E. 2010. Biotransformation of cycloastragenol by Cunninghamella blakesleeana NRRL 1369 resulting a novel framework. Org. Lett. 12(19):4252–4255.
- Kuban M, Ongen G, Khan IA, Bedir E. 2013. Microbial transformation of cycloastragenol. Phytochemistry. 88:99–104.
- Lee SY, Chang WL, Li ZX, Kirkby NS, Tsai WC, Huang SF, Ou CH, Chang TC. 2018. Astragaloside VI and cycloastragenol-6-O-beta-D-glucoside promote wound healing in vitro and in vivo. Phytomedicine. 38:183–191.
- Liu J, Zhao ZZ, Chen HB. 2011. Review of Astragali radix. Chin. Herb. Med. 3:90–105.
- Ren S, Zhang H, Mu Y, Sun M, Liu P. 2013. Pharmacological effects of Astragaloside IV: a literature review. J. Tradit. Chin. Med. 33:413–416.
- Wang C, Li Y, Yang X, Bi S, Zhang Y, Han D, Zhang D. 2017. Tetramethylpyrazine and astragaloside IV synergistically ameliorate left ventricular remodeling and preserve cardiac function in a rat myocardial infarction model. J. Cardiovasc. Pharmacol. 69:34–40.
- Yang ZW, Ye M, Huang FX, He WN, Guo DA. 2012. Biocatalysis of cycloastragenol by filamentous fungi to produce unexpected triterpenes. Adv. Synth. Catal. 354:527–539.
- Zhang CX, Ma WJ, Liu DL, Jia XJ, Zhao YM. 2018. Biotransformation of ursolic acid by Alternaria longipes AS 3.2875. Nat. Prod. Res. 32(5):536–543.
- Zhang N, Wang XH, Mao SL, Zhao F. 2011. Astragaloside IV improves metabolic syndrome and endothelium dysfunction in fructose-fed rats. Molecules. 16:3896–3907.
- Zhou RN, Song YL, Ruan JQ, Wang YT, Yan R. 2012. Pharmacokinetic evidence on the contribution of intestinal bacterial conversion to beneficial effects of astragaloside IV, a marker compound of Astragali radix, in traditional oral use of the herb. Drug Metab. Pharmacokinet. 27:586–597.